Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies—Taming T REX-Reference-Cited by-同舟云学术

Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies—Taming T REX

Published:2019-03-01 Issue:3 Volume:155 Page:283
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Damsky William¹,King Brett A.¹

Affiliation:

1. Department of Dermatology, Yale School of Medicine, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

http:///jamadermatology/article-pdf/155/3/283/17393075/jamadermatology_damsky_2019_ed_180024.pdf

Reference7 articles.

1. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.;Xing;Nat Med,2014

2. An update on autoinflammatory diseases: interferonopathies.;Davidson;Curr Rheumatol Rep,2018

3. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.;Schwartz;Nat Rev Rheumatol,2016

4. JAK inhibitors in dermatology: the promise of a new drug class.;Damsky;J Am Acad Dermatol,2017

5. Assessment of clinical response to Janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation [published online January 23, 2019].;Zimmermann;JAMA Dermatol

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cedrol in ginger (Zingiber officinale) as a promising hair growth drug: The effects of oral and external administration on hair regeneration and its mechanism;Bioorganic Chemistry;2024-10

2. Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond;International Journal of Rheumatology;2021-05-18

3. Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders;Journal of the American Academy of Dermatology;2020-03